These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29047345)

  • 1. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation.
    Mashima Y; Kigasawa K; Shinoda K; Wakakura M; Oguchi Y
    BMC Ophthalmol; 2017 Oct; 17(1):192. PubMed ID: 29047345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?
    Mashima Y; Kigasawa K; Wakakura M; Oguchi Y
    J Neuroophthalmol; 2000 Sep; 20(3):166-70. PubMed ID: 11001192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy.
    Huang CC; Kuo HC; Chu CC; Kao LY
    J Neuroophthalmol; 2002 Mar; 22(1):66. PubMed ID: 11937918
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
    Pemp B; Kircher K; Reitner A
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular nerve fibers temporal to fovea may have a greater potential to recover function in patients with Leber's hereditary optic neuropathy.
    Mashima Y; Sato EA; Ohde H; Oguchi Y
    Jpn J Ophthalmol; 2002; 46(6):660-7. PubMed ID: 12543194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and electrophysiology findings in Slovene patients with Leber hereditary optic neuropathy.
    Jarc-Vidmar M; Tajnik M; Brecelj J; Fakin A; Sustar M; Naji M; Stirn-Kranjc B; Glavač D; Hawlina M
    Doc Ophthalmol; 2015 Jun; 130(3):179-87. PubMed ID: 25690485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raxone in the Leber optical neuropathy: Parisian experience].
    Orssaud C; Bidot S; Lamirel C; Brémond Gignac D; Touitou V; Vignal C
    J Fr Ophtalmol; 2019 Mar; 42(3):269-275. PubMed ID: 30712826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.
    Catarino CB; von Livonius B; Priglinger C; Banik R; Matloob S; Tamhankar MA; Castillo L; Friedburg C; Halfpenny CA; Lincoln JA; Traber GL; Acaroglu G; Black GCM; Doncel C; Fraser CL; Jakubaszko J; Landau K; Langenegger SJ; Muñoz-Negrete FJ; Newman NJ; Poulton J; Scoppettuolo E; Subramanian P; Toosy AT; Vidal M; Vincent AL; Votruba M; Zarowski M; Zermansky A; Lob F; Rudolph G; Mikazans O; Silva M; Llòria X; Metz G; Klopstock T
    J Neuroophthalmol; 2020 Dec; 40(4):558-565. PubMed ID: 32991388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation.
    Newman NJ; Carelli V; Taiel M; Yu-Wai-Man P
    J Neuroophthalmol; 2020 Dec; 40(4):547-557. PubMed ID: 32969847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy.
    Zhao X; Zhang Y; Lu L; Yang H
    Curr Eye Res; 2020 Oct; 45(10):1315-1323. PubMed ID: 32111141
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy.
    Spruijt L; Kolbach DN; de Coo RF; Plomp AS; Bauer NJ; Smeets HJ; de Die-Smulders CE
    Am J Ophthalmol; 2006 Apr; 141(4):676-82. PubMed ID: 16564802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy].
    Barnils N; Mesa E; Muñoz S; Ferrer-Artola A; Arruga J
    Arch Soc Esp Oftalmol; 2007 Jun; 82(6):377-80. PubMed ID: 17573650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy.
    Guy J; Feuer WJ; Porciatti V; Schiffman J; Abukhalil F; Vandenbroucke R; Rosa PR; Lam BL
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):841-8. PubMed ID: 24398093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
    Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF
    Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Optic Disc Characteristics of Patients Showing Visual Recovery in Leber Hereditary Optic Neuropathy.
    Moon Y; Kim US; Han J; Ahn H; Lim HT
    J Neuroophthalmol; 2020 Mar; 40(1):15-21. PubMed ID: 31609832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for visual acuity in patients with Leber's hereditary optic neuropathy after rAAV2-ND4 gene therapy.
    Zhang Y; Li X; Yuan J; Tian Z; Liu H; Wang D; Li B
    Clin Exp Ophthalmol; 2019 Aug; 47(6):774-778. PubMed ID: 30968497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset.
    Newman NJ; Yu-Wai-Man P; Carelli V; Moster ML; Biousse V; Vignal-Clermont C; Sergott RC; Klopstock T; Sadun AA; Barboni P; DeBusk AA; Girmens JF; Rudolph G; Karanjia R; Taiel M; Blouin L; Smits G; Katz B; Sahel JA;
    Ophthalmology; 2021 May; 128(5):649-660. PubMed ID: 33451738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant and clinical landscape of Leber hereditary optic neuropathy based on 1516 families with mtDNA variants in a tertiary centre.
    Zheng Y; Wang Y; Jiang Y; Wang J; Li S; Xiao X; Sun W; Wang P; Zhang Q; Jia X
    Br J Ophthalmol; 2024 Aug; 108(9):1318-1327. PubMed ID: 38346855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
    Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
    Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical study of Leber hereditary optic neuropathy].
    Wei QP; Sun YH; Zhou XT; Zhou J; Gong XH; Jia XY
    Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1065-8. PubMed ID: 23336408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.